AnGes Inc Net Income
| AMGXF Stock | USD 0.36 0.00 0.00% |
AnGes Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated zero technical drivers for AnGes Inc, which can be compared to its peers.
AnGes' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AnGes' valuation are provided below:AnGes Inc does not currently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. AnGes |
AnGes 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AnGes' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AnGes.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in AnGes on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding AnGes Inc or generate 0.0% return on investment in AnGes over 90 days. AnGes is related to or competes with Adocia SA, and EKF Diagnostics. AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products More
AnGes Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AnGes' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AnGes Inc upside and downside potential and time the market with a certain degree of confidence.
AnGes Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AnGes' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AnGes' standard deviation. In reality, there are many statistical measures that can use AnGes historical prices to predict the future AnGes' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AnGes' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AnGes Inc Backtested Returns
We have found three technical indicators for AnGes Inc, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AnGes are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
AnGes Inc has perfect predictability. Overlapping area represents the amount of predictability between AnGes time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AnGes Inc price movement. The serial correlation of 1.0 indicates that 100.0% of current AnGes price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, AnGes Inc reported net income of (13.68 Billion). This is 4106.94% lower than that of the Healthcare sector and significantly lower than that of the Biotechnology industry. The net income for all United States stocks is significantly higher than that of the company.
AnGes Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AnGes' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of AnGes could also be used in its relative valuation, which is a method of valuing AnGes by comparing valuation metrics of similar companies.AnGes is currently under evaluation in net income category among its peers.
AnGes Fundamentals
| Return On Equity | -0.43 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (243.51) % | |||
| Current Valuation | 78.35 M | |||
| Shares Outstanding | 156.07 M | |||
| Shares Owned By Insiders | 1.66 % | |||
| Shares Owned By Institutions | 5.09 % | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 2.69 X | |||
| Revenue | 64.15 M | |||
| Gross Profit | (26 M) | |||
| EBITDA | (13.21 B) | |||
| Net Income | (13.68 B) | |||
| Cash And Equivalents | 13.21 B | |||
| Cash Per Share | 86.31 X | |||
| Current Ratio | 1.97 X | |||
| Book Value Per Share | 184.39 X | |||
| Cash Flow From Operations | (11.38 B) | |||
| Earnings Per Share | (0.65) X | |||
| Number Of Employees | 131 | |||
| Beta | 1.19 | |||
| Market Capitalization | 159.2 M | |||
| Total Asset | 45.46 B | |||
| Net Asset | 45.46 B |
About AnGes Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AnGes Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AnGes using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AnGes Inc based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in AnGes OTC Stock
AnGes financial ratios help investors to determine whether AnGes OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnGes with respect to the benefits of owning AnGes security.